xPhore | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,167 results for “xPhore”

Trials

View all 1085 →

SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma

496 participants · First posted Nov 30, 2011

Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere

44 participants · First posted May 6, 2024

Grid eXplore Mapping Study

200 participants · First posted Feb 19, 2026

Drugs

Target UDG (XPose Therapeutics)

Compound Ganoderma spore Capsule

Target POLH(XPose Therapeutics)

Organizations

View all 15 →

JINNAH HOSPITAL LAHORE

Pakistan

LAHORE GENERAL HOSPITAL

Pakistan

Micro-Sphere SA

Switzerland

News

View all 61 →

Altamira Therapeutics Expands xPhore Platform with Successful DNA Delivery Technology

Altamira Therapeutics Expands Nucleic Acid Delivery Platform with DNA Technology and Advances Spin-off Plans

Altamira Therapeutics Partners with Undisclosed Company to Advance Circular RNA Delivery Platform

Page 1 of 117